Pharmaceutical Industry Payments and Oncologists’ Selection of Targeted Cancer Therapies in Medicare Beneficiaries
- 1 June 2018
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 178 (6), 854-856
- https://doi.org/10.1001/jamainternmed.2018.0776
Abstract
This study examines the association between oncologists’ receipt of payments from pharmaceutical manufacturers and drug selection in 2 situations where there arKeywords
This publication has 4 references indexed in Scilit:
- Pharmaceutical Industry–Sponsored Meals and Physician Prescribing Patterns for Medicare BeneficiariesJAMA Internal Medicine, 2016
- Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in MassachusettsJAMA Internal Medicine, 2016
- Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing CostsPLOS ONE, 2016
- Forecasting Unanticipated Consequences of “The Sunshine Act”: Mostly CloudyJournal of Clinical Oncology, 2014